The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
about
The value of plants used in traditional medicine for drug discoverySelective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolonesUnique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolideMichellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanismsAnalysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptaseSpecific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsPlant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirusAnti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptaseStructure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilideInhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integraseHighly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolatesA Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 UpregulationChemical ecology: a view from the pharmaceutical industryApoptosis inducing activity of 4-substituted coumarins from Calophyllum brasiliense in human leukaemia HL-60 cells.High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1Bioactive compounds from Vitex leptobotrys.Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.Natural product drug discovery in the next millennium.Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjectsCurrent lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection.Review on natural coumarin lead compounds for their pharmacological activityA historical overview of natural products in drug discovery.The impact of the United Nations Convention on Biological Diversity on natural products research.Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors.Antiviral therapy for human immunodeficiency virus infectionsAntimycobacterial and HIV-1 Reverse Transcriptase Activity of Julianaceae and Clusiaceae Plant Species from Mexico.Antihuman Immunodeficiency Virus Type 1 (HIV-1) Activity of Rare Earth Metal Complexes of 4-Hydroxycoumarins in Cell Culture.Clinical utility of current NNRTIs and perspectives of new agents in this class under development.Identification of candidate genes related to calanolide biosynthesis by transcriptome sequencing of Calophyllum brasiliense (Calophyllaceae).Coumarin-based drugs: a patent review (2008 -- present).Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase.3-Phenylcoumarins as inhibitors of HIV-1 replication.F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis.Microwave-induced synthesis of schiff bases of aminothiazolyl bromocoumarins as antibacterials.Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways.Mucigerin, a new coumarin from Calophyllum mucigerum (Guttiferae).Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors.Inophyllin A, a new pyranoxanthone from Calophyllum inophyllum (Guttiferae).
P2860
Q24536929-61C33712-54E8-4CD3-AB8B-11BAEEB9B136Q24798680-884ECDFD-6374-4036-BA0C-ED723F1415A8Q28343461-ADC01197-64F2-46B1-997B-D1330D663B26Q28367673-92250DF1-D9DD-4F41-AF6A-8901213F06E1Q28368003-DD531895-22D6-4F1A-959E-2C445B7EF51DQ28368032-553602BF-3AE6-47F8-B123-6E6CBACA81DCQ28371850-BDAFD66F-57E8-49D3-8CE3-316A52F73E2AQ28378745-6065B253-EEEF-4657-8FF1-EC330919DDA4Q28378796-12A83341-CDBB-4812-94A6-03CE5C61627DQ28378926-7EC0812E-6FAF-4013-AD5E-007C84B0C586Q28379523-7CD83710-7B8A-48C1-A1C2-1781F6CF71B5Q28553032-570E950E-24D0-4730-9A22-3684590B0EB2Q30418854-560B8D73-04B0-495A-98E9-7F6580B7990BQ33248189-32B199F3-595B-4C9A-A1C2-35D64996B236Q33796791-D4F2DC9E-F13A-4F47-8244-9ACB972D21BDQ33797340-E6534A96-E4E2-4ED7-B692-5165D9D2335DQ33813305-774B36B5-29E4-4ADA-AD93-F3697F7B5272Q33893121-BEE12ABC-999D-49F0-BE3C-F59C41483B38Q33982026-DC2F95CA-D5C0-4297-B69C-30A815154174Q33996826-0F9AE8A6-16A2-48B5-96F0-66EF2F90D531Q34339290-8D5D4522-07F5-4953-A258-DA608E9697CFQ34426191-317E7779-5348-4C11-99CE-2AC19D78D4F6Q34434337-CB33B92A-3C24-4BC8-839D-7D4FB91BC223Q35204293-7480BE60-57FE-4542-B9E7-6E15DCB555F7Q35366050-58BA1AA5-D316-4CA6-978E-77E0BB3E8546Q35578829-D1228B1C-25FB-4BE1-AA19-2D88C2AF5817Q35605974-63A14D54-EF9E-4AF7-86DD-5A8CAB074318Q35842270-772D6DEC-53AE-48AB-817D-F84EB8288D79Q36104576-DC91BBEC-B03D-4BC9-9F48-0E08FCDDFE45Q37999915-352B9E01-C3BF-4645-A45F-433A8630D238Q38297932-8B3DAD7A-9457-4749-A6D5-77A07EECC08CQ39303248-1106001F-EFD4-4B4F-BBD2-326890911106Q39692280-9151D45D-8487-4BCF-BCA7-2DE33CB85B56Q39963125-A5C4836E-3D98-4D88-A200-22A401D3DC0DQ40325450-950C1D4B-6AAE-4D9B-8AA5-0D384CEB77B4Q40585869-359E8E3A-A532-4AE9-B54C-259C22F5D5ECQ40834269-F3FF6DED-F6A9-4238-BC69-78C5928CCFB7Q41200507-3064AA19-7D7F-4B11-B621-7143B50D050FQ42275289-982A8F96-B1D8-4A5F-888C-D9878A1A0FF7Q42999834-BDC92913-F2BD-4BCE-9976-BE32F4B11B45
P2860
The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@ast
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@en
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@nl
type
label
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@ast
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@en
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@nl
prefLabel
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@ast
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@en
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@nl
P2093
P3181
P356
P1476
The calanolides, a novel HIV-i ...... st tree, Calophyllum lanigerum
@en
P2093
J B McMahon
J H Cardellina
K R Gustafson
M J Currens
R W Buckheit
R W Fuller
S H Hughes
P304
P3181
P356
10.1021/JM00093A004
P407
P577
1992-07-24T00:00:00Z